Sorry, you need to enable JavaScript to visit this website.

Study of Glasdegib with Intensive or Standard Chemotherapy in Patients with Untreated Acute Myeloid Leukemia

Study of Glasdegib with Intensive or Standard Chemotherapy in Patients with Untreated Acute Myeloid
Leukemia. A Randomized (1:1), Double-Blind, Multi-Center, Placebo Controlled Study Evaluating Intensive Chemotherapy With or Without Glasdegib (PF-04449913) or Azacitidine (AZA) With or Without Glasdegib in Patients With Previously Untreated Acute Myeloid Leukemia.

Category & Conditions: Cancer
Medicine: DAURISMO TABLETS(GLASDEGIB)
ClinicalTrials.gov Identifier (NCT): NCT03416179
Protocol ID: B1371019
PrintDownload
Open Plain Language Summary Result: Click here